Search
DECAPEPTYL LP 11.25 MG, Suspension injectable en IM
Details
| --- | Description |
|---|---|
| Pack | Boîte de 1 flacon poudre + solvant |
| Strength (Dosage) | 11.25 MG |
| Laboratory | MAPHAR |
| Ingredients | Triptoréline |
| Therapeutic class | Antinéoplasique, agoniste de la GnRH |
| ATC code | L02AE04 |
| PPH | $323.90 |
| PPV | $354.60 |
| Refundable | Yes |
| Refund base | $354.60 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | · Cancer de la prostate Traitement du cancer de la prostate localement avancé ou métastatique. Traitement du cancer de la prostate localisé à haut risque ou localement avancé, en association à la radiothérapie. Un effet favorable du médicament est d'autant plus net et plus fréquent que le patient n'a pas reçu auparavant un autre traitement hormonal. · Endométriose à localisation génitale et extragénitale (du stade I au stade IV) La durée du traitement est limitée à 6 mois. Il n'est pas souhaitable d'entreprendre une seconde cure par la triptoréline ou par un autre analogue de la GnRH. · Puberté précoce centrale (avant 8 ans chez la fille, avant 10 ans chez le garçon). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem